These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21383062)

  • 21. Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss.
    Cizmecioglu O; Ni J; Xie S; Zhao JJ; Roberts TM
    Elife; 2016 Oct; 5():. PubMed ID: 27700986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.
    Graupera M; Guillermet-Guibert J; Foukas LC; Phng LK; Cain RJ; Salpekar A; Pearce W; Meek S; Millan J; Cutillas PR; Smith AJ; Ridley AJ; Ruhrberg C; Gerhardt H; Vanhaesebroeck B
    Nature; 2008 May; 453(7195):662-6. PubMed ID: 18449193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of any class IA PI3K isoform can sustain cell proliferation and survival.
    Foukas LC; Berenjeno IM; Gray A; Khwaja A; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11381-6. PubMed ID: 20534549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
    Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.
    Leverrier Y; Okkenhaug K; Sawyer C; Bilancio A; Vanhaesebroeck B; Ridley AJ
    J Biol Chem; 2003 Oct; 278(40):38437-42. PubMed ID: 12869549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism.
    Zhang X; Vadas O; Perisic O; Anderson KE; Clark J; Hawkins PT; Stephens LR; Williams RL
    Mol Cell; 2011 Mar; 41(5):567-78. PubMed ID: 21362552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.
    Yip SC; El-Sibai M; Hill KM; Wu H; Fu Z; Condeelis JS; Backer JM
    Cell Motil Cytoskeleton; 2004 Nov; 59(3):180-8. PubMed ID: 15468162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor stimulates translocation of the class II phosphoinositide 3-kinase PI3K-C2beta to the nucleus.
    Banfic H; Visnjic D; Mise N; Balakrishnan S; Deplano S; Korchev YE; Domin J
    Biochem J; 2009 Jul; 422(1):53-60. PubMed ID: 19496756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.
    Sun M; Hillmann P; Hofmann BT; Hart JR; Vogt PK
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15547-52. PubMed ID: 20713702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A beta version of life: p110β takes center stage.
    Dbouk HA; Backer JM
    Oncotarget; 2010 Dec; 1(8):729-733. PubMed ID: 21321382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors.
    Tsolakos N; Durrant TN; Chessa T; Suire SM; Oxley D; Kulkarni S; Downward J; Perisic O; Williams RL; Stephens L; Hawkins PT
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12176-12181. PubMed ID: 30442661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of phosphatidylinositol 3-kinase composed of p110beta-catalytic and p85-regulatory subunits with the small GTPase Rab5.
    Kurosu H; Katada T
    J Biochem; 2001 Jul; 130(1):73-8. PubMed ID: 11432782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of phosphoinositide 3-OH kinase p110β in skeletal myogenesis.
    Matheny RW; Riddle-Kottke MA; Leandry LA; Lynch CM; Abdalla MN; Geddis AV; Piper DR; Zhao JJ
    Mol Cell Biol; 2015 Apr; 35(7):1182-96. PubMed ID: 25605332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer.
    Hao Y; He B; Wu L; Li Y; Wang C; Wang T; Sun L; Zhang Y; Zhan Y; Zhao Y; Markowitz S; Veigl M; Conlon RA; Wang Z
    Nat Commun; 2022 Apr; 13(1):1974. PubMed ID: 35418124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation.
    de la Cruz-Herrera CF; Baz-Martínez M; Lang V; El Motiam A; Barbazán J; Couceiro R; Abal M; Vidal A; Esteban M; Muñoz-Fontela C; Nieto A; Rodríguez MS; Collado M; Rivas C
    Oncogene; 2016 Jun; 35(22):2873-80. PubMed ID: 26411363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.
    Rathinaswamy MK; Burke JE
    Adv Biol Regul; 2020 Jan; 75():100657. PubMed ID: 31611073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.
    Edgar KA; Wallin JJ; Berry M; Lee LB; Prior WW; Sampath D; Friedman LS; Belvin M
    Cancer Res; 2010 Feb; 70(3):1164-72. PubMed ID: 20103642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
    Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
    Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells.
    Houslay DM; Anderson KE; Chessa T; Kulkarni S; Fritsch R; Downward J; Backer JM; Stephens LR; Hawkins PT
    Sci Signal; 2016 Aug; 9(441):ra82. PubMed ID: 27531651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
    Matheny RW; Lynch CM; Leandry LA
    Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.